Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02474160 · ClinicalTrials.gov registry record
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
A clinical trial of Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm, sponsored by National Cancer Institute LAO.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 20
- Study locations
NCT02474160 is a study of Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm that is actively recruiting participants, run by National Cancer Institute LAO. The registered enrollment target is 5,000 participants, above the 1,112-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (350% higher). The trial reports 20 study locations across 8 states.
The verdict
NCT02474160, a study of Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm, is actively recruiting participants, sponsored by National Cancer Institute LAO.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study collects and stores tissue and blood samples from patients with cancer. Collecting and storing samples of tissue and blood from patients with cancer to study in the laboratory may help scientists create new and better models to learn about cancer and to test new cancer drugs.
Conditions Studied
Interventions
- OTHER Cytology Specimen Collection Procedure
Study Locations (20)
Illinois
- OSF Saint Joseph Medical Center - Bloomington
- Illinois CancerCare-Bloomington - Bloomington
- Illinois CancerCare-Canton - Canton
- Memorial Hospital of Carbondale - Carbondale
- Illinois CancerCare-Carthage - Carthage
- Centralia Oncology Clinic - Centralia
Delaware
- Delaware Clinical and Laboratory Physicians PA - Newark
- Helen F Graham Cancer Center - Newark
- Medical Oncology Hematology Consultants PA - Newark
- Christiana Care Health System-Christiana Hospital - Newark
- Christiana Care Health System-Wilmington Hospital - Wilmington
California
- PCR Oncology - Arroyo Grande
- City of Hope Comprehensive Cancer Center - Duarte
- USC / Norris Comprehensive Cancer Center - Los Angeles
Connecticut
- Smilow Cancer Center/Yale-New Haven Hospital - New Haven
- Yale University - New Haven
Alabama
- University of Alabama at Birmingham Cancer Center - Birmingham
Arkansas
- Mercy Hospital Fort Smith - Fort Smith
Colorado
- UCHealth University of Colorado Hospital - Aurora
Georgia
- Augusta University Medical Center - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2015-05-19 |
| Est. Completion | 2026-05-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02474160
The ClinicalTrials.gov registry entry for NCT02474160 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,112-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (350% higher). The listed sponsor is National Cancer Institute LAO, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Cytology Specimen Collection Procedure is the first listed.
NCT02474160 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Illinois, Delaware, California.
Frequently Asked Questions
What is clinical trial NCT02474160 about?
NCT02474160 is a clinical study titled "Collection and Storage of Tissue and Blood Samples From Patients With Cancer". This study collects and stores tissue and blood samples from patients with cancer. Collecting and storing samples of tissue and blood from patients with cancer to study in the laboratory may help scientists create new and better models to learn about cancer and to test new cancer drugs.
What is the current status of trial NCT02474160?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2015-05-19. Estimated completion is 2026-05-04.
What conditions does trial NCT02474160 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm, Recurrent Malignant Solid Neoplasm.
What interventions are being tested in trial NCT02474160?
The interventions under investigation include: Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT02474160?
This trial is sponsored by National Cancer Institute LAO, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02474160 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
RECRUITING
-
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
RECRUITING · NA
-
Voices: Messages of Wisdom and Hope in the Face of Illness
RECRUITING
-
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.